HIGH LINE BIO
Live / Applied — First extension granted (statement of use) (as of 25 Feb 2026)
What this means for you
Not registered yet, but its 12 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98898887
- Mark type
- Stylized text
- Filed
- 12 Dec 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for treatment of osteoarthritis, pain, inflammation, musculo-skeletal disorders, and rheumatological conditions
Owner
- High Line Bio, Inc., New York, NY, US
- High Line Bio, Inc., New York, NY, US
Prosecution history
- 26 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2026 — SOU EXTENSION 1 GRANTED
- 25 Feb 2026 — SOU EXTENSION 1 FILED
- 25 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2025 — ASSIGNED TO EXAMINER
- 12 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Dec 2024 — NEW APPLICATION ENTERED